Showing 2621-2630 of 5771 results for "".
- Novartis Announces Intention to Spinoff Alcon Into Standalone Companyhttps://modernod.com/news/novartis-announces-intention-to-spinoff-alcon-and-launch-a-5-billion-share-buyback/2480055/After months of speculation, Novartis confirmed on Friday its intention to spinoff Alcon into a separately-traded standalone company. The major transaction would enable Novartis to focus on bringing new drugs to market, while allowing Alcon to focus on its core offerings in the surgical and visio
- Kala Pharmaceuticals Announces Update to KPI-121 0.25% Development Planhttps://modernod.com/news/kala-pharmaceuticals-announces-update-to-kpi-121-0-25-development-plan/2480081/Kala Pharmaceuticals provided an update on the development plan for KPI-121 0.25%, which if approved could be the first FDA-approved product for the short-term treatment of dry eye disease.
- Allergan Announces Former Abbott Executive to Join Board of Directors as Part of “Refreshment Process”https://modernod.com/news/allergan-announces-former-abbott-executive-to-join-board-of-directors-as-part-of-refreshment-process/2480087/Allergan on Thursday said that former Abbott Laboratories executive Thomas Freyman will be joining its board with immediate effect. CEO Brent Saunders remarked “[Freyman] has nearly four decades of industry experience including finance leadership and serving on multiple public boards, makin
- EyeSouth Announces Strategic Partnership with South Georgia/North Florida Eye Partnershttps://modernod.com/news/eyesouth-announces-strategic-partnership-with-south-georgia-north-florida-eye-partners/2480107/EyeSouth Partners has completed a strategic partnership with South Georgia/North Florida Eye Partners, and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions. EyeSouth is an eye care-focused physician services organization f
- Sylentis Announces New Data on the Treatment of Allergic Conjunctivitishttps://modernod.com/news/sylentis-announces-new-data-on-the-treatment-of-allergic-conjunctivitis/2480172/At the ARVO meeting, Sylentis presented preclinical results on its RNAi therapy, demonstrating how SYL116011 acts on seasonal ocular allergies SYL116011, which is being researched for ocular allergies caused by pollen, reduces the symptoms related to allergy, such as swelling and tearing,
- Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndromehttps://modernod.com/news/sylentis-announces-the-clinical-results-of-tivanisiran-for-the-treatment-of-dry-eye-syndrome/2480178/At the ARVO meeting, Sylentis presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome, and that has enabled the start-up of the phase 3 “Helix” clinical trial. Sylentis presented the preclinical and clinical results of vari
- Vance Thompson Vision Announces New Clinic and LASIK and Cataract Center in Omahahttps://modernod.com/news/vance-thompson-vision-announces-new-clinic-and-lasik-and-cataract-center-in-omaha/2480189/Vance Thompson Vision is scheduled to open a new clinic in Omeha, Nebraska, in August and will include a focus on cataract surgery, minimally invasive glaucoma surgery, LASIK, and corneal surgery. Brandon Baartman, MD, is an accomplished refractive, cataract,
- USC Roski Eye Institute Scientists Present Latest Research at the ARVO Annual Meetinghttps://modernod.com/news/usc-roski-eye-institute-scientists-present-latest-research-at-the-arvo-annual-meeting/2480198/What do nanophotoswitches, lipid nanoparticles, and mapping the brain have in common? They are among the future-forward areas of vision research being investigated by USC Roski Eye Institute
- Blanchard Announces Notching Technology for the Onefit Family of Scleral Lenses: Control Peripheral Recesshttps://modernod.com/news/blanchard-announces-notching-technology-for-the-onefit-family-of-scleral-lenses-control-peripheral-recess/2480206/Blanchard Contact Lenses has unveiled their latest design option for its Onefit and Onefit MED scleral lenses. Control Peripheral Recess (CPR) is a manufacturing process that creates
- ianTECH’s miLOOP Grabs Two “Best Paper of Session” Wins at the ASCRS-ASOA Annual Meetinghttps://modernod.com/news/iantechs-miloop-grabs-two-best-paper-of-session-wins-at-the-ascrs-asoa-annual-meeting/2480210/Two presentations among the several featuring ianTECH’s novel »miLOOP Device won “Best Paper in Session” awards during the 2018 meeting of the American Society of Catarac